Abstract
Human NAD(P)H:quinone oxidoreductase (hNQO1) can be used as a biomarker for the early diagnosis of cancer. In this article, a novel fluorescent probe 1 for detecting hNQO1 was designed and synthesized by using 2-dicyanomethylene-3-cyano-4,5,5-trimethyl-2,5-dihydrofuran (TCF) derivative (TCF-OH) as a fluorophore and quinone propionic acid (QPA) as a recognition group. The probe, which has high selectivity for hNQO1 and a Stokes shift of about 117 nm, shows a linear relationship with hNQO1 concentrations in the range of 0.25-3 μg ml-1 with the color changes from yellow to red and was successfully applied to intracellular hNQO1 imaging.
Cite
CITATION STYLE
Zhu, Y., Han, J., Zhang, Q., Zhao, Z., Wang, J., Xu, X., … Zhang, J. (2019). A highly selective fluorescent probe for human NAD(P)H:quinone oxidoreductase 1 (hNQO1) detection and imaging in living tumor cells. RSC Advances, 9(46), 26729–26733. https://doi.org/10.1039/c9ra05650e
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.